Abstract
The COVID-19 pandemic has had tremendous impact worldwide but possibly no other patient subset has been impacted as much as patients with a cancer diagnosis. Significantly increased morbidity and mortality was defined amongst identifiable subsets of cancer patients, such as the elderly, patients with co-morbid illnesses and certain malignancy types and therapies. In addition, major compromises in cancer care and drastic drop-offs in cancer screening rates have led to significant further setbacks in recent advances in cancer care. Emerging information as to the benefit of COVID-19 vaccinations, including booster vaccines that can benefit even the most immune suppressed along with novel anti-COVID antibodies preemptively reduce the risk of infection. Antiviral and other therapeutics mitigating the severity of COVID-19 infections now offer major insights, new and effective options and hope for being able to optimize cancer care even in the face of the ongoing pandemic. Székely B, Halmos B. COVID-19 and cancer patients – Scylla and Charybdis of the 21st century. Magy Onkol 66:35-41, 2022.
| Original language | Hungarian |
|---|---|
| Pages (from-to) | 35-41 |
| Number of pages | 7 |
| Journal | Magyar Onkologia |
| Volume | 66 |
| Issue number | 1 |
| State | Published - 2022 |
Keywords
- COVID-19
- coronavirus
- epidemic
- oncology
- pandemic
ASJC Scopus subject areas
- Oncology
